Canna Law Blog

NOVEMBER 10, 2020

We discussed how licensed facilities won’t be up and running for a few more years, and how, in the meantime, people will have to make do with general decriminalization under Measure 109 and maybe, in certain cases, reliance on Right to Try access. Unlike with many precursor state laws, no institutional review board review is required.

Therapy 79

Therapy Clinical Trials Decriminalization Patients 79

NORML

JANUARY 4, 2019

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. Click here to email your member of Congress and urge them to join the Cannabis Caucus. MA resident?

Legislation 126

Legislation Clinical Trials Research and Development Access 126

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. At the state level, patients in Ohio and Oklahoma now have access to medical cannabis, as sales began in both states this week. Additionally, a bipartisan coalition of U.S.

Legislation 163

Legislation Decriminalization Access Therapy 163

The Blunt Truth

AUGUST 13, 2019

Current federal law expressly allows for the distribution of hemp-derived CBD products that contain 0.3% Other CBD products, however, are still subject to various state law regulations as well as the U.S. To further complicate matters, there has been a flurry of activity at the state level.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Canna Law Blog

MARCH 4, 2020

Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ).

Therapy 90

Therapy Legalization Chronic Pain DEA 90

Canna Law Blog

MARCH 4, 2020

Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ).

Legalization 52

Legalization Therapy Chronic Pain DEA 52

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. The Department is opposing the bill on grounds that it will create significant problems by bringing the state into conflict with federal laws designed to prevent money laundering.

Banking 45

Banking Research and Development Legislation Programs 45